Care PMS

PMS Rating

IME PMS Rating

AMC does not meet our selection criteria at this time

Not a recommended AMC: For a PMS started by a group of CA's without past investment experience, Care PMS has done reasonably well in terms of scaling up their business & fund performance. However, it is yet to fully prove its credentials as a credible PMS player.

The PMS/AIF AMC Rating is derived on the basis of our analysis on 5 key qualitative parameters that we use to analyse the quality of a PMS/AIF Provider. These include an assessment of the size of the AMC, the pedigree of the AMC, the pedigree of the team, the value of the investment philosophy & the level of differentiation. These insights of our central research team are documented in the IME RMS, and can be accessed during a consultation call with an IME PMS specialist.

PMS Background

Discretionary AUM (579cr) | Promoter Category ()

PMS Background

Care PMS was founded in 2011, by a team of chartered accountants with a dream of becoming a trusted portfolio manager for their clients.

PMS Investment Philosophy

Care PMS runs 2 strategies: 

  • Growth Plus Value strategy: a multi-cap portfolio that combines growth & value (with a greater focus on value & smaller companies)
  • Large & mid-cap strategy: focus on the top 250 companies by market cap


  1. Shortlisting of companies on ongoing basis (on fundamental trigger) or during quarterly earnings season (after applying their own quant screeners) for detailed anlysis. 
  2. Performing extensive fundamental research on shortlisted stocks and their peer group to spot trend or turnaround in that segment or industry. 
  3. Take account of recent developments in that segment or industry and meet industry participants across the value chain to confirm inferences 
  4. Detailed analysis of company’s strategies, management’s ability to execute and pedigree of management followed by Q&A with management or investor relations. 
  5. Decision to add a company or replace an existing company taken only after consensus among 3 investment directors.


  • Stock Selection: Stocks selected after analysing financials and due diligence as per their Investment Criterion. Mostly invest in dominant player in a segment
  • Portfolio Construction: Constructed based on complying with controls and observing them such as individual stock exposure and sector exposure limits. Diversify between growth ideas, turnarounds and value buys
  • Portfolio Review: Portfolio is then reviewed on the basis of quantitative review of portfolio holding, supervision and monitoring to position portfolio with investment team directives
  • Exit and Replace: When stock price appreciates to its fair value or reaches their target or if there is a change in business fundamentals– Sell. Replacement of existing portfolio done when there is an availability of an alternate investment.


  • Disproportionate Risk-reward
  • Restriction on single sector/company
  • Diversification
  • Continuous monitoring  

Focus on business with Growth Potential, Management Capabilities, Strong Financials, available at compelling valuations

Inv Team

Investment Team

Arpit Shah | 2-star rated FM

Joint MD | 17 yrs at current firm

Arpit Shah is the founder of the company and is a CA.

Amit Doshi | 2-star rated FM

Fund Manager | 19 yrs Experience | 15 yrs at current firm

Past Experience: Manager (PwC)

Amit Doshi is a CA by qualification. He joined Care Portfolio Managers in December 2009 after his role at PwC.

Jayant Mamania | 2-star rated FM

Fund Manager

He is key personnel of the investment team. His stock picking ability makes Care PMS a distinct portfolio manager. He heads the investment team and has over 20 years of experience.

PMS/AIF Schemes

PMS & Listed Equity AIF Schemes

No items found

Returns as of 31-May-24.

Free 30-Day Trial of the IME RMS

Details shared above, are only a short-snapshot of the more detailed analysis that resides in IME’s Proprietary RMS (Research Management Solution).

The IME RMS is the first tool ever, to give investors direct access to the insights of the central research team. Investors gain direct access to our ratings, rating rationales & analysis across thousands of funds (MFs, PMSs, AIFs, Global funds), asset classes, categories & more.

 Learn More